Track: Dyslipidemia and Risk factors

Heart 2023 Conference - Dyslipidemia and Risk factors


Dyslipidemia Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027 is a recent study from Transparency Market Research (TMR). The report estimates that the market for pharmaceuticals to treat dyslipidemia was worth US$ 11.8 billion in 2018 and would grow at a CAGR of 3.5% from 2019 to 2027. From 2019 to 2027, rising illness awareness thanks to promotional campaigns and an increase in the prevalence of people with abnormal cholesterol and triglyceride levels will be the key market drivers for dyslipidemia medications worldwide.


·        Epidemiology of cardiovascular diseases and risk factors
·        Epidemiology of dyslipidemias
·        Diabetes, insulin sensitivity and resistance
·        Adipose tissue homeostasis
·        Inherited dyslipidemias
·        Gender and cardiovascular risk
·        Environmental risk factors
·        Novel risk factors and biomarkers
·        Epidemiology of socioeconomic and psychosocial risk factors
·        Coagulation
·        Gut microbiome
·        Gene editing technology
·        Genomics, GWAS and population genetics; Mendelian randomization
·        Epigenetics and microRNA
·        Gene-Environment interactions 

Related Hospitals: Cleveland ClinicMayo Clinic, New York-Presbyterian Hospital, Cedars-Sinai Medical CenterMassachusetts General Hospital, NewYork-Presbyterian Hospital-Columbia and Cornell, Johns Hopkins HospitalNYU Langone Hospitals, Northwestern Memorial Hospital, Hospitals of the University of Pennsylvania-Penn Presbyterian, Mount Sinai HospitalUniversity of Michigan Hospitals and Health Centers, Duke University HospitalBrigham and Women's Hospital, Barnes-Jewish Hospital, UCLA Medical Center, Stanford Health Care-Stanford Hospital, Heart Hospital Baylor Plano, Houston Methodist Hospital, Loyola University Medical Center, NYU Langone Medical Center, UPMC Presbyterian Shadyside, Scripps La Jolla Hospitals, Ohio State University Wexner Medical Center, UCSF Medical Center, Sentara Norfolk General Hospital-Sentara Heart Hospital, Texas Heart Institute at Baylor St. Luke's Medical Center, Beaumont Hospital-Royal Oak, Minneapolis Heart Institute at Abbott Northwestern Hospital, Vanderbilt University Medical Center, Memorial Hermann-Texas Medical Center, The University of Alabama at Birmingham Hospital, University of Colorado HospitalSt. Francis Hospital.